Home
/
INVO Fertility, Inc.
/
Financials
/
Quarterly
INVO Fertility, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that INVO Fertility, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.76M
Nov 17, 2025
Q2
2025
Jun 30, 2025
$1.86M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$1.64M
May 20, 2025
Q3
2025
Sep 30, 2024
$1.43M
Nov 17, 2025
Q2
2025
Jun 30, 2024
$1.84M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$1.58M
May 20, 2025
Q3
2020
Sep 30, 2020
$336.1K
Nov 16, 2020
Q2
2020
Jun 30, 2020
$246.1K
Aug 13, 2020
Q1
2020
Mar 31, 2020
$258.6K
May 15, 2020
Q3
2020
Sep 30, 2019
$303.6K
Nov 16, 2020
Q2
2020
Jun 30, 2019
$658.6K
Aug 13, 2020
Q1
2020
Mar 31, 2019
$189.4K
May 15, 2020
Q3
2019
Sep 30, 2018
$125.0K
Nov 14, 2019
Q2
2019
Jun 30, 2018
$110.2K
Aug 14, 2019
Q1
2019
Mar 31, 2018
$104.1K
May 15, 2019
Q3
2018
Sep 30, 2017
$68.2K
Nov 14, 2018
Q2
2018
Jun 30, 2017
$80.3K
Aug 14, 2018
Q1
2018
Mar 31, 2017
$52.2K
May 15, 2018
Q3
2017
Sep 30, 2016
$17.8K
Nov 14, 2017
Q2
2016
Jun 30, 2016
$5.4K
Sep 5, 2017
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Mar 31, 2025
$1.64M
May 20, 2025
Q3
2024
Sep 30, 2024
$1.43M
Nov 19, 2024
Q2
2024
Jun 30, 2024
$1.84M
Nov 19, 2024
Q1
2025
Mar 31, 2024
$1.58M
May 20, 2025
Q3
2024
Sep 30, 2023
$974.9K
Nov 19, 2024
Q2
2024
Jun 30, 2023
$315.9K
Nov 19, 2024
Q1
2024
Mar 31, 2023
$348.0K
May 15, 2024
Q3
2023
Sep 30, 2022
$235.3K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$146.1K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$162.6K
May 15, 2023
Q3
2022
Sep 30, 2021
$218.9K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$208.5K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$684.5K
May 16, 2022
Q3
2021
Sep 30, 2020
$336.1K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$246.1K
Aug 16, 2021
Q1
2021
Mar 31, 2020
$258.6K
May 17, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.64M)
Nov 17, 2025
Q2
2025
Jun 30, 2025
($5.28M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($5.28M)
Nov 17, 2025
Q3
2025
Mar 31, 2025
($17.40M)
Nov 17, 2025
Q1
2025
Mar 31, 2025
($17.40M)
May 20, 2025
Q2
2025
Mar 31, 2025
($17.40M)
Aug 14, 2025
Q3
2025
Sep 30, 2024
($1.63M)
Nov 17, 2025
Q3
2025
Jun 30, 2024
($2.25M)
Nov 17, 2025
Q2
2025
Jun 30, 2024
($2.25M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($1.60M)
Nov 17, 2025
Q1
2025
Mar 31, 2024
($1.60M)
May 20, 2025
Q2
2025
Mar 31, 2024
($1.60M)
Aug 14, 2025
Q3
2024
Sep 30, 2023
($1.25M)
Nov 19, 2024
Q3
2024
Jun 30, 2023
($2.24M)
Nov 19, 2024
Q2
2024
Jun 30, 2023
($2.24M)
Nov 19, 2024
Q1
2024
Mar 31, 2023
($2.55M)
May 15, 2024
Q2
2024
Mar 31, 2023
($2.55M)
Nov 19, 2024
Q3
2024
Mar 31, 2023
($2.55M)
Nov 19, 2024
Q3
2023
Sep 30, 2022
($2.55M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($2.80M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.64M)
Nov 17, 2025
Q2
2025
Jun 30, 2025
($2.99M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($17.11M)
May 20, 2025
Q3
2025
Sep 30, 2024
($1.30M)
Nov 17, 2025
Q2
2025
Jun 30, 2024
($1.85M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($1.51M)
May 20, 2025
Q3
2024
Sep 30, 2023
($886.3K)
Nov 19, 2024
Q2
2024
Jun 30, 2023
($2.07M)
Nov 19, 2024
Q1
2024
Mar 31, 2023
($2.31M)
May 15, 2024
Q3
2023
Sep 30, 2022
($2.53M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($2.68M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($2.70M)
May 15, 2023
Q3
2022
Sep 30, 2021
($2.27M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($1.89M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.56M)
May 16, 2022
Q3
2021
Sep 30, 2020
($1.27M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.06M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($1.40M)
May 17, 2021
Q3
2020
Sep 30, 2019
($632.4K)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($65.8K)
Aug 13, 2020